Mizuho lowered the firm’s price target on Medical Properties Trust (MPW) to $5 from $6 and keeps a Neutral rating on the shares. The firm says that despite healthcare real estate investment trusts’ outperformance in fiscal 2024, it continues to like the subsector into fiscal 2025, but feels “some rotation is warranted. Mizuho reiterates a positive stance on senior housing and shifted to neutral from positive on the skilled nursing facility group. It recommends rotating into life sciences as it sees venture funding improving through the year.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MPW:
- Medical Properties Trust price target lowered to $3 from $3.50 at BofA
- Medical Properties Trust prospect to sell managed care unit to Astrana for $745M
- Medical Properties Trust Reports Q3 2024 Results
- Medical Properties Trust reports Q3 normalized FFO 16c, consensus 20c
- MPW Upcoming Earnings Report: What to Expect?